Management holds a conference call to discuss Tavapadon in Parkinson’s Disease on December 11 at 10 am. Webcast Link
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CERE:
- Cerevel Therapeutics just downgraded at TD Cowen, here’s why
- Cerevel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next
- Cerevel Therapeutics downgraded to Neutral from Overweight at Piper Sandler
- Cerevel Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald